Filter
1459
Filtered Results: 1459
Text search:
candidates
Featured
Recommendations
128
New Publications
321
Language
Document type
No document type
747
Studies & Reports
259
Guidelines
204
Manuals
84
Fact sheets
57
Strategic & Response Plan
54
Training Material
17
Resource Platforms
14
Situation Updates
8
Videos
7
Brochures
4
Online Courses
4
Countries / Regions
India
66
Global
49
Latin America and the Carribbean
30
Western and Central Europe
30
Congo, Democratic Republic of
29
South Africa
28
Kenya
27
Africa
27
Brazil
23
Ethiopia
23
Nepal
22
Liberia
22
Zambia
21
Senegal
20
West and Central Africa
19
Mozambique
18
Russia
18
Benin
17
Nigeria
17
Rwanda
15
Sierra Leone
14
Syria
14
Malawi
14
East and Southern Africa
14
Philippines
13
Tanzania
13
Bangladesh
13
Myanmar / Burma
13
Ukraine
12
Guinea
12
Eastern Europe
12
Colombia
11
Haiti
11
Germany
11
Middle East and North Africa
11
Uganda
11
Ghana
9
Cameroon
9
Burkina Faso
8
Argentina
8
Angola
8
Cambodia
7
Venezuela
7
South Sudan
7
Indonesia
7
Eastern Europe and Central Asia
6
Paraguay
6
Central African Republic
6
El Salvador
5
China
5
Peru
5
Zimbabwe
5
USA
5
Spain
5
Namibia
5
Madagascar
5
North Macedonia
4
Lesotho
4
Chile
4
Asia
4
Guinea-Bissau
4
South–East Asia Region
3
Bolivia
3
Yemen
3
Botswana
3
Tajikistan
2
Thailand
2
Mexico
2
Turkey
2
Albania
2
Lithuania
2
France
2
Portugal
2
Georgia
2
Mali
2
Switzerland
1
Timor Leste/ East Timor
1
Togo
1
Kazakhstan
1
Iran
1
Canada
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Morocco
1
Italy
1
Hungary
1
Jordan
1
Western Pacific Region
1
Uruguay
1
Jamaica
1
United Kingdom
1
Norway
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Somalia
1
Ecuador
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
528
Clinical Guidelines
123
Public Health
68
Key Resources
51
Women & Child Health
41
Pharmacy & Technologies
23
Capacity Building
16
Annual Report MEDBOX
1
Toolboxes
COVID-19
215
Mental Health
127
HIV
77
TB
75
NTDs
74
Disability
65
Ebola & Marburg
59
Rapid Response
58
Caregiver
47
AMR
28
Conflict
27
Refugee
23
Planetary Health
23
NCDs
16
Natural Hazards
14
Pharmacy
13
Health Financing Toolbox
12
Global Health Education
11
Social Ethics
8
Zika
8
Polio
5
Cholera
4
Typhoon
4
Specific Hazards
2
Malaria
2
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial particip...
Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet misinformation about the safety and effects of any future vaccine is already threatening its rollout. In...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation of vaccine hesitancy. Vaccine efficacy is often highly variable betwee...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vaccine types as well as the phases of clinical develo...
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain areas associated with mood regulation. Finally, I d...
A Estratégia Conjunta Continental Africana para a COVID-19 é sustentada pela necessidade de limitar a transmissão, prevenir mortes e reduzir os danos associados. A participação das nações africanas em ensaios clínicos é um passo essencial para garantir que sejam gerados dados suficientes so...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality. ...
Visit the Ebola Outbreak page on NEJM.org for a collection of articles and other resources, including powerful, personal essays with first-hand reporting from caregivers in the field, an interactive graphic with information on past and present Ebola outbreaks, and an audio interview with NIAID Direc...
La stratégie continentale commune africaine pour COVID-19 est sous-tendue par la nécessité de limiter la transmission, de prévenir les décès et de réduire les dommages associés. La participation des nations africaines aux essais cliniques est une étape essentielle pour garantir la productio...
Vacunas
recommended
COVID Reference 23 May 2021
Vaccines
recommended
COVID Reference 23 May 2021
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the COVID-19 Vaccine BIBP/ Sinopharm, th...
